Publicacións en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (2)

2022

  1. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

    Lung Cancer, Vol. 173, pp. 83-93

2002

  1. Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advance carcinoma of the pancreas

    Annals of Oncology, Vol. 13, Núm. 11, pp. 1756-1762